AG-120 in People With IDH1 Mutant Chondrosarcoma

Clinical trial NCT04278781 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04278781
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chondrosarcoma Chondrosarcoma, Grade 2 Chondrosarcoma, Grade 3 IDH1 Gene Mutation

Start date: 2020-03-04
Primary completion: 2027-03-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.